Bajaj Healthcare Launches Generic Favipiravir Tablets For Co
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Drug firm Bajaj Healthcare on May 4 announced the launch of its antiviral Favipiravir tablets under the brand name 'Favijaj' used for the treatment of mild to moderate COVID-19 infections in the country. The company has received approval from India's drug regulator DCGI to manufacture and market the tablets, Bajaj Healthcare said in a BSE filing.

"We hope the availability of an effective treatment such as Favijaj will considerably ease the pressure and offer patients much-needed and timely therapy options," Bajaj Healthcare Joint MD Anil Jain said.

The company has successfully developed the active pharmaceutical ingredient (API) and the formulation for favipiravir through its own in-house R&D team, Bajaj Healthcare said.

Source:
https://www.newindianexpress.com/business/2021/may/04/bajaj-healthcare-launches-generic-favipiravir-tablets-for-covid-19-treatment-2298371.html
Like
Comment
Share